Roland Fiskesund
Huddinge, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
MALNC: a new mutant NPM1/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response.
Journal: Cancer gene therapy
Published: March 28, 2025
Publisher Correction: Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1.
Journal: Nature immunology
Published: November 07, 2023
Cell softness renders cytotoxic T lymphocytes and T leukemic cells resistant to perforin-mediated killing.
Journal: Nature communications
Published: March 12, 2023
Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1.
Journal: Nature immunology
Published: March 05, 2023
MTH1 as a target to alleviate T cell driven diseases by selective suppression of activated T cells.
Journal: Cell death and differentiation
Published: August 28, 2021
Cell Softness Prevents Cytolytic T-cell Killing of Tumor-Repopulating Cells.
Journal: Cancer research
Published: July 28, 2020
Immunoglobulin G1 Antibodies Against Phosphorylcholine Are Associated With Protection in Systemic Lupus Erythematosus and Atherosclerosis: Potential Underlying Mechanisms.
Journal: ACR open rheumatology
Published: May 22, 2019
Publisher Correction: Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype.
Journal: Nature communications
Published: May 03, 2018
Mechanisms by Which Dendritic Cells Present Tumor Microparticle Antigens to CD8+ T Cells.
Journal: Cancer immunology research
Published: December 11, 2017
STAT3/p53 pathway activation disrupts IFN-β-induced dormancy in tumor-repopulating cells.
Journal: The Journal of clinical investigation
Published: July 19, 2017
Last Updated: 09/26/2026